Yıl: 2022 Cilt: 23 Sayı: 1 Sayfa Aralığı: 58 - 62 Metin Dili: İngilizce DOI: 10.5152/TurkThoracJ.2022.21045 İndeks Tarihi: 15-05-2023

Co-infection of COVID-19 and Tuberculosis

Öz:
OBJECTIVE: Tuberculosis and COVID-19 diseases occur more frequently in people with similar risk factors. This study aimed to share the data on active tuberculosis patients during the severe acute respiratory syndrome coronavirus 2 pandemic. MATERIAL AND METHODS: The registration information of TB outpatient clinic between November 1, 2019, and April 20, 2020, was screened. A 7-question survey was administered to the patients who were diagnosed with active tuberculosis and who were agreed to participate in the study. RESULTS: A total of 309 patients with active tuberculosis were evaluated, the average age of the patients was 42.5 ± 18.5 years, and 70% were male. The percentage of having at least 1 comorbidity was 30.4%. The percentage of coronavirus disease 2019 disease in our study population was 1.9%; none of the patients of coronavirus disease 2019 were taken into the intensive care unit or dead due to clinical deterioration and/or respiratory failure. On the other hand, in this process it was announced that 146 457 cases were diagnosed with coronavirus disease 2019 throughout the country, of which 72% had inpatient treatment, 2% died, and 944 patients were still being treated in the intensive care unit, of which 490 were intubated. The positivity ratio of the reverse transcription-polymerase chain reaction test was 20.0% in the study group, while 20.3% in the İstanbul population. CONCLUSION: Tuberculosis patients might be more disadvantageous than the normal population in terms of the risk of exposure to severe acute respiratory syndrome coronavirus 2, but this does not cause an increase in the frequency and severity of coronavirus disease 2019 disease in active tuberculosis patients.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. [CrossRef]
  • 2. Hui DS, Azhar EI, Madani TA, et al. The continuing 2019- nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264-266. [CrossRef]
  • 3. Zhang DH, Wu KL, Zhang X, Deng SQ, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. 2020;18(2):152-158. [CrossRef]
  • 4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [CrossRef]
  • 5. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281-286. [CrossRef]
  • 6. Wei W, Zhang S, Fleming J, et al. Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features. FASEB J. 2019;33(1):1496-1509. [CrossRef]
  • 7. Tadolini M, Codecasa LR, García-García JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020;56(1). [CrossRef]
  • 8. Liu Y, Bi L, Chen Y, et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. medRxiv. 2020. [CrossRef]
  • 9. World Health Organization (WHO). World Health Organiza- tion (WHO) Information Note Tuberculosis and COVID-19. Geneva: WHO; 2020.
  • 10. Comstock GW. Epidemiology of tuberculosis. The American review of respiratory disease. 1982;125(3 Pt 2):8-15.
  • 11. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207. [CrossRef]
  • 12. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177-1179. [CrossRef]
  • 13. Stead WW, Lofgren JP, Warren E, Thomas C. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med. 1985;312(23):1483-1487. [CrossRef]
  • 14. Cegielski JP, McMurray DN. The relationship between malnutri- tion and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis. 2004;8(3):286-298.
  • 15. Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthri- tis Rheum. 2006;55(1):19-26. [CrossRef]
  • 16. Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42(11):1592-1595. [CrossRef]
  • 17. Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuber- culosis disease among persons with diabetes mellitus: a pro- spective cohort study. Clin Infect Dis. 2012;54(6):818-825. [CrossRef]
  • 18. Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial. 2003;16(1):38-44. [CrossRef].
  • 19. Inghammar M, Ekbom A, Engström G, et al. COPD and the risk of tuberculosis-a population-based cohort study. PLoS One. 2010;5(4):e10138. [CrossRef]
  • 20. World Health Organization (WHO). World Health Organiza- tion Global TB rReport 2019. Available at: https://www.who.int/ tb/publications/global_report/en/.
  • 21. T.C. Sağlık Bakanlığı. Tüberküloz İstatistikleri. Available at: https ://hsgm.saglik.gov.tr/tr/tuberkuloz-istatistikler.html.
  • 22. T.C. Sağlık Bakanlığı. Genel Koronavirüs Tablosu. Turkey: Min- istry of Health. Available at: https://covid19.saglik.gov.tr/TR-66 935/genel-koronavirus-tablosu.html.
  • 23. Toraks. Turkish Thoracic Society Press Release. 2020. Availa- ble at: https://www.toraks.org.tr/userfiles/file/Defin%20Basın% 20Bülten-MYK%20SON.pdf.
  • 24. Wu Z, McGoogan JM. Characteristics of and important lessons From the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. [CrossRef]
  • 25. Pathak Y, Mishra A, Tripathi V. Rifampicin may be re-purposed for COVID-19 treatment: insights from an in-silico study. Research Square; 2020.
APA Kılıç l, ALTIN S, ortaköylü m, Kanmaz D, Ozkan G, Tutar T (2022). Co-infection of COVID-19 and Tuberculosis. , 58 - 62. 10.5152/TurkThoracJ.2022.21045
Chicago Kılıç lütfiye,ALTIN SEDAT,ortaköylü mediha gönenç,Kanmaz Dilek,Ozkan Gulcihan,Tutar Tayjen Co-infection of COVID-19 and Tuberculosis. (2022): 58 - 62. 10.5152/TurkThoracJ.2022.21045
MLA Kılıç lütfiye,ALTIN SEDAT,ortaköylü mediha gönenç,Kanmaz Dilek,Ozkan Gulcihan,Tutar Tayjen Co-infection of COVID-19 and Tuberculosis. , 2022, ss.58 - 62. 10.5152/TurkThoracJ.2022.21045
AMA Kılıç l,ALTIN S,ortaköylü m,Kanmaz D,Ozkan G,Tutar T Co-infection of COVID-19 and Tuberculosis. . 2022; 58 - 62. 10.5152/TurkThoracJ.2022.21045
Vancouver Kılıç l,ALTIN S,ortaköylü m,Kanmaz D,Ozkan G,Tutar T Co-infection of COVID-19 and Tuberculosis. . 2022; 58 - 62. 10.5152/TurkThoracJ.2022.21045
IEEE Kılıç l,ALTIN S,ortaköylü m,Kanmaz D,Ozkan G,Tutar T "Co-infection of COVID-19 and Tuberculosis." , ss.58 - 62, 2022. 10.5152/TurkThoracJ.2022.21045
ISNAD Kılıç, lütfiye vd. "Co-infection of COVID-19 and Tuberculosis". (2022), 58-62. https://doi.org/10.5152/TurkThoracJ.2022.21045
APA Kılıç l, ALTIN S, ortaköylü m, Kanmaz D, Ozkan G, Tutar T (2022). Co-infection of COVID-19 and Tuberculosis. Turkish Thoracic Journal, 23(1), 58 - 62. 10.5152/TurkThoracJ.2022.21045
Chicago Kılıç lütfiye,ALTIN SEDAT,ortaköylü mediha gönenç,Kanmaz Dilek,Ozkan Gulcihan,Tutar Tayjen Co-infection of COVID-19 and Tuberculosis. Turkish Thoracic Journal 23, no.1 (2022): 58 - 62. 10.5152/TurkThoracJ.2022.21045
MLA Kılıç lütfiye,ALTIN SEDAT,ortaköylü mediha gönenç,Kanmaz Dilek,Ozkan Gulcihan,Tutar Tayjen Co-infection of COVID-19 and Tuberculosis. Turkish Thoracic Journal, vol.23, no.1, 2022, ss.58 - 62. 10.5152/TurkThoracJ.2022.21045
AMA Kılıç l,ALTIN S,ortaköylü m,Kanmaz D,Ozkan G,Tutar T Co-infection of COVID-19 and Tuberculosis. Turkish Thoracic Journal. 2022; 23(1): 58 - 62. 10.5152/TurkThoracJ.2022.21045
Vancouver Kılıç l,ALTIN S,ortaköylü m,Kanmaz D,Ozkan G,Tutar T Co-infection of COVID-19 and Tuberculosis. Turkish Thoracic Journal. 2022; 23(1): 58 - 62. 10.5152/TurkThoracJ.2022.21045
IEEE Kılıç l,ALTIN S,ortaköylü m,Kanmaz D,Ozkan G,Tutar T "Co-infection of COVID-19 and Tuberculosis." Turkish Thoracic Journal, 23, ss.58 - 62, 2022. 10.5152/TurkThoracJ.2022.21045
ISNAD Kılıç, lütfiye vd. "Co-infection of COVID-19 and Tuberculosis". Turkish Thoracic Journal 23/1 (2022), 58-62. https://doi.org/10.5152/TurkThoracJ.2022.21045